Posted: February 1st, 2017

Explain the “Injurious” element of the current FTC policy on deception. (24 points) (A 1½-page response is required.)

Lesson 3: Brand Management

Discussion Question 2 (24 points)

Upon completion of the Required Readings, write a thorough, well-planned narrative answer to each of the following discussion questions. Rely on your Required Readings and the Lecture and Research Update for specific information to answer each discussion question, but turn to your original thoughts when asked to apply, evaluate, analyze, or synthesize the information. Appropriately cite all resources used to answer the discussion questions and include an APA-formatted bibliography for each. Your Discussion Question responses should be both grammatically and mechanically correct, and formatted in the same fashion as the questions themselves. If there is a Part A, your response should identify a Part A, etc.

Respond to the following:

a. Explain the distinctions between ethics and morals.

b. In 1997, the Food and Drug Administration loosened its controls on pharmaceutical companies, and as a result, the amount of prescription drug advertising has skyrocketed. What is a disadvantage of this regulatory change?

c. Explain the “Reasonableness” element of the current FTC policy on deception.

d. Explain the “Injurious” element of the current FTC policy on deception. (24 points) (A 1½-page response is required.)

ACTIVITY 03 MK640 Marketing and Advertising